4//SEC Filing
Tribute Pharmaceuticals Canada Inc. 4
Accession 0001357211-14-000002
CIK 0001159019operating
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 6:23 PM ET
Size
8.0 KB
Accession
0001357211-14-000002
Insider Transaction Report
Form 4
Harris Robert Paul
DirectorChief Executive Officer
Transactions
- Award
Share Options
2014-02-06$0.36/sh+189,617$68,262→ 1,314,343 totalExercise: $0.36From: 2015-03-31Exp: 2019-02-06→ Common Shares (189,617 underlying) - Disposition to Issuer
Share Options
2014-03-31$0.56/sh−172,454$96,574→ 1,141,514 totalExercise: $0.56From: 2014-03-31Exp: 2016-12-01→ Common Shares (172,454 underlying)
Footnotes (3)
- [F1]converted to CAD @ $0.40
- [F2]Converted to CAD @ $0.57
- [F3]These are performance based options which will vest as 23,702 on each of Mar 31, Jun 30, Sep 30 and Dec 31 in each of 2015 and 2016.
Documents
Issuer
Tribute Pharmaceuticals Canada Inc.
CIK 0001159019
Entity typeoperating
IncorporatedOntario, Canada
Related Parties
1- filerCIK 0001159019
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 6:23 PM ET
- Size
- 8.0 KB